Prostate cancer screening and Gleason score: empirical clinical practice
- PMID: 39162816
- DOI: 10.1007/s00428-024-03900-x
Prostate cancer screening and Gleason score: empirical clinical practice
Similar articles
-
Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam.Int J Urol. 2017 Apr;24(4):281-286. doi: 10.1111/iju.13294. Epub 2017 Feb 7. Int J Urol. 2017. PMID: 28173626
-
The Association Between Age, Prostate Cancer Risk, and Higher Gleason Score in a Long-term Screening Program: Results from the Göteborg-1 Prostate Cancer Screening Trial.Eur Urol. 2022 Sep;82(3):311-317. doi: 10.1016/j.eururo.2022.01.018. Epub 2022 Feb 1. Eur Urol. 2022. PMID: 35120773 Clinical Trial.
-
Prostate-specific antigen velocity and prostate cancer gleason grade and stage.Cancer. 2007 Apr 15;109(8):1689-95. doi: 10.1002/cncr.22558. Cancer. 2007. PMID: 17330856
-
Gleason 6 Prostate Cancer: Translating Biology into Population Health.J Urol. 2015 Sep;194(3):626-34. doi: 10.1016/j.juro.2015.01.126. Epub 2015 Apr 4. J Urol. 2015. PMID: 25849602 Free PMC article. Review.
-
Current perspectives on the Gleason grading of prostate cancer.Arch Pathol Lab Med. 2009 Nov;133(11):1810-6. doi: 10.5858/133.11.1810. Arch Pathol Lab Med. 2009. PMID: 19886716 Review.
References
-
- Egevad L, Micoli C, Delahunt B, Samaratunga H, Orrason AW, Garmo H, StattinP, Eklund M (2024) Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study. Virchows Arch. https://doi.org/10.1007/s00428-024-03810-y .
-
- Takahashi T (2023) Two conflicting guidelines on prostate specific antigen screening in Japan. Jpn J Clin Oncol 53(3):280–283. https://doi.org/10.1093/jjco/hyac192 - DOI - PubMed
-
- Chodak GW, Schoenberg HW (1989) Progress and problems in screening for carcinoma of the prostate. World J Surg. 13(1):60–4. https://doi.org/10.1007/BF01671155 - DOI - PubMed
-
- Swanson G (1996) Survival and conservative treatment for localized prostate cancer. JAMA 275(1):31. https://doi.org/10.1001/jama.275.1.31b . (author reply 32) - DOI - PubMed
-
- Albertsen PC, Hanley JA, Gleason DF, Barry MJ (1998) Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280(11):975–980. https://doi.org/10.1001/jama.280.11.975 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources